VC Profile: Jeito Capital in final stretch of biotech fund deployment
At a time when many big-ticket GPs are buying up specialist life science investors, France-based Jeito Capital is focused on staying an independent investor as it gears up to deploy the remaining third of its EUR 534m debut fund, founder Rafaèle Tordjman tells Unquote.
More on GPs
H2 turns to bilateral talks to get Optegra sale over the line, sources say
Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month
MidEuropa takes majority stake in Optegra
H2 Equity reinvests with minority share; sale saw interest from Partners, HIG, CapVest
GP Profile: EV Private Equity outlines plans for dedicated energy transition fund
Energy sector investor prepares to raise EUR 350m for Article 9 fund targeting renewable, clean tech businesses
KKR invests in CVC's French insurer April Group
US sponsor to become new majority owner; company achieved its objectives more than a year in advance
Latest News
Adams Street raises USD 1.1bn for 2022 Global Fund Program
Latest co-mingled vehicle is around a third larger than previous two programmes in the series
H2 turns to bilateral talks to get Optegra sale over the line, sources say
Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month
AgriBriefing sale draws bid from Five Arrows-backed Mintec
Vendor Horizon collected offers for the agricultural information services provider last week
LP Profile: Stonehage Fleming anticipates largest ever PE programme in 2023
Multi-family office will doubling down on manager selectivity, opportunities in secondaries, and family offices' interest in increasing PE exposure